Dr. Mary Anepohl Norman, MD

Dr. Norman practices at Robertson Surgical Institute in Beverly Hills, California.

Dr. Norman's NPI, 1811002454, was assigned on August 21, 2006. Dr. Norman graduated from University of California, San Francisco School of Medicine in 1997. Dr. Norman holds California license A68182.

Dr. Norman's primary practice is Robertson Surgical Institute, at 250 N Robertson Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 919-4179.

Dr. Norman's primary practice is Robertson Surgical Institute in Beverly Hills, California. Dr. Norman is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Norman to 2 more home health agencies, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Norman practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Norman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Norman is board certified in geriatric medicine by the American Board of Internal Medicine. Dmand AI has Dr. Norman's licenses on file in 5 states: California, Texas, North Carolina, Colorado and Kansas.

Dmand AI lists alzheimer's disease, cardiomyopathy, chronic diabetes, chronic hypertension, chronic kidney disease, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Norman treats.

CMS data shows 337 Medicare services from Dr. Norman across 7 procedure codes in 2024, for 96 Medicare patients. Medicare paid $28,738 for them. Every service was in an office.

CMS counts 96 Medicare patients who saw Dr. Norman in 2024. The largest group is 75 to 84, with 41 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Norman's median patient age at 77, with 65% women.

In 2024, Dr. Norman wrote 3,457 Medicare Part D claims for 357 patients. 89% of them were for generic drugs. CMS names the drug for 2,750 of them, across 72 drugs with 11 or more claims each, at $179,705 in total drug cost. In 2023, CMS named 235 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Norman for performance year 2024, reported as part of a group. Dr. Norman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Norman as offering telehealth.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Norman, published from 2019 to 2024. 2024 was the busiest year, with 3. The most frequent topics are Alzheimer Disease, Cognitive Dysfunction and Disclosure. Dr. Norman has published most often in Alzheimers Dement. Dr. Norman's most frequent co-authors are Alireza Atri, MD, PhD, Bradford Clark Dickerson, MD and David S. Knopman, MD.

CMS Open Payments shows 3 general payments to Dr. Norman from 3 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $42.

Dmand AI lists 2 awards for Dr. Norman, most recently CMS Stage 1 EHR in 2013.

Dr. Norman graduated from University of California, San Francisco School of Medicine in 1997. Dr. Norman is a member of AMA.

Dr. Norman is in network with 14 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.